PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE

PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE was reported 89 times

PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 76 0.0288
1 GLP-2 Analog [EPC] 7 0.0005
2 Echinocandin Antifungal [EPC] 2 0.0002
3 Lipopeptide Antibacterial [EPC] 2 0.0002
4 Somatostatin Analog [EPC] 1 0.0001
5 Provitamin D2 Compound [EPC] 4 0.0001
6 Bile Acid [EPC] 3 0.0001
7 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
8 Progesterone [EPC] 2 0.0001
9 Bile Acid Sequestrant [EPC] 1 0.0001
10 Parenteral Iron Replacement [EPC] 1 0.0001
11 Anticholinergic [EPC] 1 0.0001
12 Rifamycin Antibacterial [EPC] 2 0.0001
13 Penem Antibacterial [EPC] 1 0.0000
14 Arteriolar Vasodilator [EPC] 2 0.0000
15 Polyene Antifungal [EPC] 1 0.0000
16 Aminoglycoside Antibacterial [EPC] 1 0.0000
17 Copper-containing Intrauterine Device [EPC] 1 0.0000
18 Ester Local Anesthetic [EPC] 1 0.0000
19 Opioid Agonist [EPC] 5 0.0000
20 Methylxanthine [EPC] 1 0.0000
21 Glycopeptide Antibacterial [EPC] 1 0.0000
22 Non-Standardized Chemical Allergen [EPC] 1 0.0000
23 Amide Local Anesthetic [EPC] 1 0.0000
24 Central Nervous System Stimulant [EPC] 1 0.0000
25 Antiarrhythmic [EPC] 1 0.0000
26 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
27 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
28 Factor Xa Inhibitor [EPC] 1 0.0000
29 Osmotic Laxative [EPC] 1 0.0000
30 beta-Adrenergic Blocker [EPC] 1 0.0000
31 Vitamin B12 [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 1 0.0000
35 Corticosteroid [EPC] 1 0.0000